Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

153 trials

NCT06971380
Recruiting
Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
Phase 2 · Israel · 1 site
Registry update: 4 Nov 2026
NCT06354322
Recruiting
Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis
Not applicable · France · 1 site
Registry update: 2 Sept 2025
NCT06855121
Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
Not applicable · Norway · 23 sites
Registry update: 20 Jul 2026
NCT05098665
Recruiting
PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
Not applicable · United Kingdom · 1 site
Registry update: 16 Jun 2026
NCT06836011
Recruiting
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
Not applicable · Austria, Germany, Italy, Netherlands · 8 sites
Registry update: 19 Feb 2025
NCT06768489
Recruiting
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Phase 1 · Australia, Spain, Israel, Netherlands, United States · 16 sites
Registry update: 25 Sept 2026
NCT06527521
Recruiting
Prevalence of Amyloidosis in Trauma Patients
Not applicable · Spain · 1 site
Registry update: 27 Oct 2026
NCT06569147
Recruiting
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
Phase 1/2 · United States · 5 sites
Registry update: 19 Aug 2026
NCT06627309
Recruiting
Rapid dFLC Response Predict CHR in AL Amyloidosis
Not applicable · China · 8 sites
Registry update: 9 Mar 2026
NCT07314268
Recruiting
ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers
Not applicable · Brazil · 1 site
Registry update: 2 Jan 2026
NCT07033715
Recruiting
Exercise in Hereditary ATTR (ATTRv) Amyloidosis
Not applicable · Portugal · 1 site
Registry update: 24 Jun 2025
NCT06458374
Recruiting
ATTR Cardiac Amyloidosis in a Selected Population
Not applicable · Norway · 1 site
Registry update: 12 Aug 2026
NCT07124377
Recruiting
Phenotypic Manifestations of Hereditary ATTR Amyloidosis
Not applicable · Argentina · 2 sites
Registry update: 2 Apr 2026
NCT06292780
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Phase 1/2 · Germany, Spain, United Kingdom, Greece, South Korea, Netherlands, Taiwan, United States · 33 sites
Registry update: 18 Aug 2026
NCT06338696
Recruiting
Thailand ATTR-CM Registry
Not applicable · Thailand · 8 sites
Registry update: 8 May 2025
NCT06420167
Recruiting
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
Phase 2 · United States · 1 site
Registry update: 26 Jun 2026
NCT05797857
Recruiting
Exercise Training in Transthyretin Cardiac Amyloidosis
Not applicable · United States · 1 site
Registry update: 18 Mar 2025
NCT06427304
Recruiting
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Not applicable · France · 36 sites
Registry update: 20 Apr 2026
NCT06573723
Recruiting
Institutional Registry of Rare Diseases
Not applicable · Argentina · 1 site
Registry update: 14 Jan 2026
NCT06022939
Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Phase 3 · United States · 117 sites
Registry update: 6 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.